Antigenic linear peptide compounds

Details Antigenic linear peptide compounds Antigenic linear peptide compounds

1981-05-26

1982-10-12

Phillips, Delbert R.

Chemistry of carbon compounds

Miscellaneous organic carbon compounds

C-metal

C07C10352

Patent

active

043538223

ABSTRACT:
The novel antigenic linear peptide compounds of this invention are characterized by providing a sequence of eight amino acids comprising isoleucine-serine-glycine-phenylalanine-proline-valine-glycine-arginine, all of the amino acids with the exception of glycine being in their L-forms. The isoleucine may comprise the N-terminal end or may be bonded to N-terminal glycine, and the arginine may be the C-terminal amino acid or may be bonded to C-terminal valine. The compounds have utility in vaccines for reducing the fertility of mammals.

REFERENCES:
patent: 4310456 (1982-01-01), Goldberg
Chem. Abstr. vol. 95, (1981) pp. 128346w, vol. 78, (1973) pp. 41298g.
Musick, et al., J. Biol. Chem. 254, 1979, 7621-7623.

Affiliated with

Also associated with

Rating

Antigenic linear peptide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antigenic linear peptide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic linear peptide compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-222818